---
figid: PMC8197834__ijms-22-05676-g002
figtitle: Ceramide and Related Molecules in Viral Infections
organisms:
- Human immunodeficiency virus 1
- Severe acute respiratory syndrome coronavirus 2
- Hepatitis B virus
- Adenoviridae
- Influenza A virus
- Coronaviridae
- Human alphaherpesvirus 1
- Human immunodeficiency virus
- Human papillomavirus
- Severe acute respiratory syndrome-related coronavirus
- unidentified influenza virus
- Dengue virus
- Respiratory syncytial virus
- Human betaherpesvirus 5
- H1N1 subtype
- Vesicular stomatitis virus
- Vaccinia virus
- Zika virus
- West Nile virus
- H5N1 subtype
- Ebola virus
- Measles morbillivirus
- Betapolyomavirus macacae
- Japanese encephalitis virus
- Human alphaherpesvirus 2
- Coxsackievirus B3
- Encephalomyocarditis virus
- Sindbis virus
- Enterovirus
- Human coronavirus 229E
- H3N2 subtype
- Semliki Forest virus
- Human rhinovirus sp.
- Human orthopneumovirus
- Murine leukemia virus
- Infectious bronchitis virus
- Variola virus
- Human metapneumovirus
- Murine norovirus
- Human parvovirus B19
- Alphapapillomavirus 7
- Theilers encephalomyelitis virus
- Rubella virus
- Feline calicivirus
- Norovirus GII.4
- H1N1 swine influenza virus
- Norovirus GII.3
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Sus scrofa
- Trypanosoma cruzi
- NA
- NA
organisms_ner:
- Mus musculus
- Drosophila melanogaster
pmcid: PMC8197834
filename: ijms-22-05676-g002.jpg
figlink: /pmc/articles/PMC8197834/figure/ijms-22-05676-f002/
number: F2
caption: 'Sphingolipid metabolism. Ceramide is the central hub of sphingolipid metabolism.
  De novo synthesis (blue) starts with palmitoyl CoA, and the salvage pathway starts
  with conversion to sphingosine and ends with a fatty aldehyde and ethanolamine-phosphate
  (green). The synthesis of glycosphingolipids starts with the formation of glucosylceramide
  (purple). Other key pathways are phosphorylation to ceramide-1-phosphate (blue-gray),
  conversion to sphingomyelin (orange) and glycosylation to α-galactosylceramide and
  sulfatide (yellow). Inhibitors of ceramide-metabolizing enzymes are shown in red.
  Cer: ceramide; GlcCer: glucosylceramide; S1P: sphingosine 1-phosphate; SM: sphingomyelin.'
papertitle: Ceramide and Related Molecules in Viral Infections.
reftext: Nadine Beckmann, et al. Int J Mol Sci. 2021 Jun;22(11):5676.
year: '2021'
doi: 10.3390/ijms22115676
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: ceramide | acid sphingomyelinase | sphingolipids | lipid-rafts | α-galactosylceramide
  | viral infection | antiviral therapies | immunomodulation | SARS-CoV-2 | HIV-1
  | IAV
automl_pathway: 0.9061676
figid_alias: PMC8197834__F2
figtype: Figure
redirect_from: /figures/PMC8197834__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8197834__ijms-22-05676-g002.html
  '@type': Dataset
  description: 'Sphingolipid metabolism. Ceramide is the central hub of sphingolipid
    metabolism. De novo synthesis (blue) starts with palmitoyl CoA, and the salvage
    pathway starts with conversion to sphingosine and ends with a fatty aldehyde and
    ethanolamine-phosphate (green). The synthesis of glycosphingolipids starts with
    the formation of glucosylceramide (purple). Other key pathways are phosphorylation
    to ceramide-1-phosphate (blue-gray), conversion to sphingomyelin (orange) and
    glycosylation to α-galactosylceramide and sulfatide (yellow). Inhibitors of ceramide-metabolizing
    enzymes are shown in red. Cer: ceramide; GlcCer: glucosylceramide; S1P: sphingosine
    1-phosphate; SM: sphingomyelin.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cacybp
  - Trp53inp1
  - Tsacc
  - Sipd1
  - Skic2
  - Hps3
  - tst
  - cer
  - sm
  - se
  - Coa
  - de
---
